Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Actinomycin D
COSMEGEN ® _Actinomycin D (pronounced ak-ti-noe-_ _mye-sin di)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about COSMEGEN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using COSMEGEN against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT COSMEGEN IS USED FOR COSMEGEN is used alone, or in combination with other chemotherapy or radiotherapy, to treat certain types of cancers, including: Wilms’ tumour, a type of kidney cancer Rhabdomyosarcoma, a cancer of the muscle Nonseminomatous testicular carcinoma, a cancer of the testis Choriocarcinoma, a cancer of the uterus Ewing’s sarcoma, a type of bone cancer Sarcoma botryoides, a cancer of the female reproductive tract. COSMEGEN may also be used to treat the symptoms of certain cancers, or to treat tumours that are not responding to radiotherapy. It may also be used in people who are having a tumour surgically removed. COSMEGEN belongs to a group of medicines called antineoplastics. It works by interfering with the growth of cancer cells, which are eventually killed. Your doctor may have prescribed COSMEGEN for another reason. Ask your doctor if you have any questions about why COSMEGEN has been prescribed for you. COSMEGEN is not addictive. BEFORE YOU ARE GIVEN COSMEGEN _WHEN YOU MUST NOT BE GIVEN_ _COSMEGEN_ DO NOT USE COSMEGEN IF YOU HAVE AN ALLERGY TO COSMEGEN OR ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. DO NOT USE COSMEGEN IF YOU HAVE RECENTLY HAD OR Read the complete document
COSMEGEN (ACTINOMYCIN D) NAME OF THE MEDICINE Actinomycin D COSMEGEN (actinomycin D) is one of the actinomycins, a group of antibiotics produced by various species of Streptomyces. Actinomycin D is the principle component of the mixture of actinomycins produced by Streptomyces parvullus. The toxic properties of the actinomycins in relation to antibacterial activity preclude their use as antibiotics in the treatment of infectious diseases; however, they have an antineoplastic effect which has been demonstrated in experimental animals with various types of tumour implant. This cytotoxic action is the basis for their use in the palliative treatment of certain types of cancer. Actinomycin D is one of the actinomycins, a group of antibiotics produced by various species of Streptomyces. Actinomycin D is the principal component of the mixture of actinomycins produced by Streptomyces parvullus. Unlike other species of Streptomyces, this organism yields an essentially pure substance that contains only traces of similar compounds differing in the amino acid content of the peptide side chains. The molecular formula is C62H86N12O16, and the structural formula is: Actinomycin D Chemical Abstract Registry Number is 50-76-0. DESCRIPTION COSMEGEN is a sterile, yellow lyophilised powder for injection by the intravenous route or by regional perfusion after reconstitution. Each vial contains 0.5 mg (500 mcg) of actinomycin D and 20.0 mg of mannitol. 1 COSi-07 PHARMACOLOGY ACTIONS Generally, the actinomycins exert an inhibitory effect on gram-positive and gram-negative bacteria and on some fungi. However, the toxic properties of the actinomycins (including actinomycin D) in relation to antibacterial activity are such as to preclude their use as antibiotics in the treatment of infectious Read the complete document